Comparison of three commercial batches of the Japanese encephalitis vaccine IC51. Double blind, randomized, controlled phase 3 study
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2013
At a glance
- Drugs IC 51 (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- Sponsors Intercell
- 22 Jun 2008 Actual completion date is changed from Feb 2008 to June 2008 as reported by ClinicalTrials.gov.
- 10 Mar 2008 Status changed from in progress to completed.
- 01 Feb 2008 New trial record.